|
Should You Be Tested for a KRAS Mutation?
 If you are being treated for metastatic colon or rectal cancer, you should ask your doctor about testing your tumor for changes in the KRAS gene. Research now shows that patients with mutated KRAS in their tumors do not benefit from Erbitux® (cetuximab) or Vectibix™ (panitumumab).
Is KRAS testing right for you?
KRAS research reports from the 2008 American Society of Clinical Oncology meeting
C3 Weighs in on Medicare Coverage of Virtual Colonoscopies
 The Centers for Medicare and Medicaid Services (CMS) is considering whether or not to cover the cost of virtual colonoscopies for Medicare patients. C3 believes that Americans should have access to colorectal cancer screening according to the guidelines developed by the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Last week, C3 submitted official comments to the agency in support of virtual colonoscopies.
Continue reading...
FDA Needs Money… Senator Arlen Specter vs. the Bush Administration
 The need for an influx of $275 million at the Food and Drug Administration (FDA) is so apparent that there is a battle going on about who is going to actually provide it to the agency. Senator Arlen Specter (PA), the longtime Republican senator who has been a proponent of investing in biomedical research took on the Bush Administration over funding.
Continue reading...
Support C3
 Your tax-deductible donation will allow us to continue our work that will make a difference in the lives of people living with colorectal cancer. Invest in C3 today.
|
C3 Advocates Can Send Well Wishes to Senator Ted Kennedy
 Senator Ted Kennedy (D-MA) is a strong advocate in the fight against cancer and is the lead sponsor of the Senate companion bill to The Colorectal Cancer Prevention, Early Detection, and Treatment Act (HR 1738), which is expected to be introduced soon. C3 wishes the Senator a speedy recovery following his recent cancer surgery. You can wish him well through a form on his senate website.
Answers to Your Colorectal Cancer Questions
1-877-4CRC-111
(1-877-427-2111)
C3's Answer Line is a free of charge service for patients and caregivers to get information about colorectal cancer, treatment options, clinical trials and supportive care.
Answer Line Associates are ready to take your call Monday through Friday from 9:00 AM to 5:00 PM Eastern time (calls received after hours will be returned within one business day).
Your Online Resource for Colorectal Cancer Information
With over 100 pages of patient information, policy position papers and the latest information in research and treatment news, you can rely on C3’s newly-redesigned website to bring you reliable and up-to-date information about colorectal cancer. Log on today. |
